Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines

Leukemia Research
Viengthong LamGerald J Goldenberg

Abstract

The relationship between p53 gene status and the expression of DR5 and Fas was evaluated as a function of sensitivity of 11 acute lymphoblastic leukemia cell lines to adriamycin, etoposide, vincristine, methotrexate and dexamethasone. There was up to a 37-fold increase in expression of DR5 following treatment with ADR or VP-16 only in cells with wt p53. A direct correlation was observed between enhanced DR5 expression and sensitivity to ADR and VP-16. There was no induction of DR5 following treatment with VCR, MTX or DEX. There was up to a 51-fold increase in the median level of expression of Fas following treatment with ADR and VP-16, and unlike DR5 this occurred in cells with either wild-type or mutant p53. Nevertheless, a direct correlation was observed between Fas expression and drug-sensitivity. Conversely, there was only a two-fold increase in expression of Fas after exposure to VCR, MTX and DEX. These findings suggest that DR5 mediates sensitivity to ADR and VP-16 in a p53-dependent manner, whereas, Fas appears to mediate sensitivity to these two drugs independent of p53 status. DR5 and Fas do not appear to play a major role as determinants of chemosensitivity to VCR, MTX and DEX.

References

Jan 1, 1980·International Review of Cytology·A H WyllieA R Currie
Sep 1, 1993·Chemical Research in Toxicology·A H Corbett, N Osheroff
Jun 4, 1997·Journal of the National Cancer Institute·O MicheauM T Dimanche-Boitrel
Aug 1, 1997·Nature Genetics·C M Knudson, S J Korsmeyer
Nov 5, 1997·The Journal of Biological Chemistry·M MacFarlaneE S Alnemri
Nov 5, 1997·Nature Genetics·G S WuW S el-Deiry
Jan 7, 1998·Science·E H ChengJ M Hardwick
Jun 4, 1998·Biochemical and Biophysical Research Communications·N Fujita, T Tsuruo
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Aug 28, 1998·Science·D R Green, J C Reed
Dec 8, 1998·The Journal of Experimental Medicine·M MüllerP H Krammer
Mar 13, 1999·The Journal of Biological Chemistry·D E Wood, E W Newcomb
Jul 20, 1999·The Journal of Biological Chemistry·D G KirschJ M Hardwick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.